APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sterile Formulation Development

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Sterile Formulation Development Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 January 2026190 pages

Choose your research edition.

Industry ResearchSterile Formulation Development Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Sterile Formulation Development Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Sterile Formulation Development Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sterile Formulation Development Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Sterile Formulation Development Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Sterile Formulation Development market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Sterile Formulation Development is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sterile Formulation Development is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sterile Formulation Development is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Sterile Formulation Development is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sterile Formulation Development include Catalent, Lonza Group AG, Recipharm AB, Samsung Biologics, Aenova Group, Thermo Fisher Scientific, Pfizer CentreOne, Piramal Pharma Solutions and Ardena, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Sterile Formulation Development market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sterile Formulation Development and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sterile Formulation Development revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Sterile Formulation Development market size, projected growth trends, production technologies, key applications, and end-use industries.

Sterile Formulation Development Segment by Company

Catalent

Lonza Group AG

Recipharm AB

Samsung Biologics

Aenova Group

Thermo Fisher Scientific

Pfizer CentreOne

Piramal Pharma Solutions

Ardena

Curida

Curia Global

Carbogen Amcis

Oakwood Labs

Cambrex

Almac Group

Asymchem Group

AGC Biologics

WuXi AppTec

Althea

Baxter

Sterile Formulation Development Segment by Type

Liquid Dosage Form

Lyophilized Dosage Form

Frozen Dosage Form

Others

Sterile Formulation Development Segment by Application

Preclinical

Clinical

Commercial

Sterile Formulation Development Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sterile Formulation Development market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sterile Formulation Development and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sterile Formulation Development.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Sterile Formulation Development in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sterile Formulation Development industry.

Chapter 3: Detailed analysis of Sterile Formulation Development companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sterile Formulation Developmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Sterile Formulation Development Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Liquid Dosage Form Table 3. Key Players of Lyophilized Dosage Form Table 4. Key Players of Frozen Dosage Form Table 3. Key Players of Others Table 4. Global Sterile Formulation Development Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Preclinical Table 6. Key Players of Clinical Table 7. Key Players of Commercial Table 8. Global Sterile Formulation Development Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Sterile Formulation Development Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Sterile Formulation Development Market Share by Region (2021-2026) Table 11. Global Sterile Formulation Development Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Sterile Formulation Development Market Share by Region (2027-2032) Table 13. Sterile Formulation Development Industry Trends Table 14. Sterile Formulation Development Industry Drivers Table 15. Sterile Formulation Development Industry Opportunities and Challenges Table 16. Sterile Formulation Development Industry Restraints Table 17. Global Sterile Formulation Development Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Sterile Formulation Development Revenue Market Share by Company (2021-2026) Table 19. Global Sterile Formulation Development Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Sterile Formulation Development Key Company Head Office and Area Served Table 21. Global Sterile Formulation Development Company, Product Type & Application Table 22. Global Sterile Formulation Development Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Sterile Formulation Development by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Sterile Formulation Development Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Sterile Formulation Development Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Sterile Formulation Development Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Sterile Formulation Development Revenue Market Share by Type (2021-2026) Table 29. Global Sterile Formulation Development Revenue Market Share by Type (2027-2032) Table 30. Global Sterile Formulation Development Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Sterile Formulation Development Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Sterile Formulation Development Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Sterile Formulation Development Revenue Market Share by Application (2021-2026) Table 34. Global Sterile Formulation Development Revenue Market Share by Application (2027-2032) Table 35. Catalent Company Information Table 36. Catalent Business Overview Table 37. Catalent Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Catalent Sterile Formulation Development Product Portfolio Table 39. Catalent Recent Development Table 40. Lonza Group AG Company Information Table 41. Lonza Group AG Business Overview Table 42. Lonza Group AG Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Lonza Group AG Sterile Formulation Development Product Portfolio Table 44. Lonza Group AG Recent Development Table 45. Recipharm AB Company Information Table 46. Recipharm AB Business Overview Table 47. Recipharm AB Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Recipharm AB Sterile Formulation Development Product Portfolio Table 49. Recipharm AB Recent Development Table 50. Samsung Biologics Company Information Table 51. Samsung Biologics Business Overview Table 52. Samsung Biologics Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Samsung Biologics Sterile Formulation Development Product Portfolio Table 54. Samsung Biologics Recent Development Table 55. Aenova Group Company Information Table 56. Aenova Group Business Overview Table 57. Aenova Group Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Aenova Group Sterile Formulation Development Product Portfolio Table 59. Aenova Group Recent Development Table 60. Thermo Fisher Scientific Company Information Table 61. Thermo Fisher Scientific Business Overview Table 62. Thermo Fisher Scientific Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Thermo Fisher Scientific Sterile Formulation Development Product Portfolio Table 64. Thermo Fisher Scientific Recent Development Table 65. Pfizer CentreOne Company Information Table 66. Pfizer CentreOne Business Overview Table 67. Pfizer CentreOne Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Pfizer CentreOne Sterile Formulation Development Product Portfolio Table 69. Pfizer CentreOne Recent Development Table 70. Piramal Pharma Solutions Company Information Table 71. Piramal Pharma Solutions Business Overview Table 72. Piramal Pharma Solutions Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Piramal Pharma Solutions Sterile Formulation Development Product Portfolio Table 74. Piramal Pharma Solutions Recent Development Table 75. Ardena Company Information Table 76. Ardena Business Overview Table 77. Ardena Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Ardena Sterile Formulation Development Product Portfolio Table 79. Ardena Recent Development Table 80. Curida Company Information Table 81. Curida Business Overview Table 82. Curida Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Curida Sterile Formulation Development Product Portfolio Table 84. Curida Recent Development Table 85. Curia Global Company Information Table 86. Curia Global Business Overview Table 87. Curia Global Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Curia Global Sterile Formulation Development Product Portfolio Table 89. Curia Global Recent Development Table 90. Carbogen Amcis Company Information Table 91. Carbogen Amcis Business Overview Table 92. Carbogen Amcis Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Carbogen Amcis Sterile Formulation Development Product Portfolio Table 94. Carbogen Amcis Recent Development Table 95. Oakwood Labs Company Information Table 96. Oakwood Labs Business Overview Table 97. Oakwood Labs Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Oakwood Labs Sterile Formulation Development Product Portfolio Table 99. Oakwood Labs Recent Development Table 100. Cambrex Company Information Table 101. Cambrex Business Overview Table 102. Cambrex Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Cambrex Sterile Formulation Development Product Portfolio Table 104. Cambrex Recent Development Table 105. Almac Group Company Information Table 106. Almac Group Business Overview Table 107. Almac Group Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Almac Group Sterile Formulation Development Product Portfolio Table 109. Almac Group Recent Development Table 110. Asymchem Group Company Information Table 111. Asymchem Group Business Overview Table 112. Asymchem Group Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Asymchem Group Sterile Formulation Development Product Portfolio Table 114. Asymchem Group Recent Development Table 115. AGC Biologics Company Information Table 116. AGC Biologics Business Overview Table 117. AGC Biologics Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. AGC Biologics Sterile Formulation Development Product Portfolio Table 119. AGC Biologics Recent Development Table 120. WuXi AppTec Company Information Table 121. WuXi AppTec Business Overview Table 122. WuXi AppTec Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. WuXi AppTec Sterile Formulation Development Product Portfolio Table 124. WuXi AppTec Recent Development Table 125. Althea Company Information Table 126. Althea Business Overview Table 127. Althea Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. Althea Sterile Formulation Development Product Portfolio Table 129. Althea Recent Development Table 130. Baxter Company Information Table 131. Baxter Business Overview Table 132. Baxter Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 133. Baxter Sterile Formulation Development Product Portfolio Table 134. Baxter Recent Development Table 135. North America Sterile Formulation Development Market Size by Type (2021-2026) & (US$ Million) Table 136. North America Sterile Formulation Development Market Size by Type (2027-2032) & (US$ Million) Table 137. North America Sterile Formulation Development Market Size by Application (2021-2026) & (US$ Million) Table 138. North America Sterile Formulation Development Market Size by Application (2027-2032) & (US$ Million) Table 139. North America Sterile Formulation Development Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. North America Sterile Formulation Development Market Size by Country (2021-2026) Table 141. North America Sterile Formulation Development Market Size by Country (2027-2032) Table 142. Europe Sterile Formulation Development Market Size by Type (2021-2026) & (US$ Million) Table 143. Europe Sterile Formulation Development Market Size by Type (2027-2032) & (US$ Million) Table 144. Europe Sterile Formulation Development Market Size by Application (2021-2026) & (US$ Million) Table 145. Europe Sterile Formulation Development Market Size by Application (2027-2032) & (US$ Million) Table 146. Europe Sterile Formulation Development Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Sterile Formulation Development Market Size by Country (2021-2026) Table 148. Europe Sterile Formulation Development Market Size by Country (2027-2032) Table 149. China Sterile Formulation Development Market Size by Type (2021-2026) & (US$ Million) Table 150. China Sterile Formulation Development Market Size by Type (2027-2032) & (US$ Million) Table 151. China Sterile Formulation Development Market Size by Application (2021-2026) & (US$ Million) Table 152. China Sterile Formulation Development Market Size by Application (2027-2032) & (US$ Million) Table 153. Asia Sterile Formulation Development Market Size by Type (2021-2026) & (US$ Million) Table 154. Asia Sterile Formulation Development Market Size by Type (2027-2032) & (US$ Million) Table 155. Asia Sterile Formulation Development Market Size by Application (2021-2026) & (US$ Million) Table 156. Asia Sterile Formulation Development Market Size by Application (2027-2032) & (US$ Million) Table 157. Asia Sterile Formulation Development Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Asia Sterile Formulation Development Market Size by Country (2021-2026) Table 159. Asia Sterile Formulation Development Market Size by Country (2027-2032) Table 160. South America, Middle East & Africa Sterile Formulation Development Market Size by Type (2021-2026) & (US$ Million) Table 161. South America, Middle East & Africa Sterile Formulation Development Market Size by Type (2027-2032) & (US$ Million) Table 162. South America, Middle East & Africa Sterile Formulation Development Market Size by Application (2021-2026) & (US$ Million) Table 163. South America, Middle East & Africa Sterile Formulation Development Market Size by Application (2027-2032) & (US$ Million) Table 164. South America, Middle East & Africa Sterile Formulation Development Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. South America, Middle East & Africa Sterile Formulation Development Market Size by Country (2021-2026) Table 166. South America, Middle East & Africa Sterile Formulation Development Market Size by Country (2027-2032) Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Sterile Formulation Development Product Image Figure 2. Global Sterile Formulation Development Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Sterile Formulation Development Market Share by Type: 2025 VS 2032 Figure 4. Liquid Dosage Form Image Figure 5. Lyophilized Dosage Form Image Figure 6. Frozen Dosage Form Image Figure 7. Others Image Figure 8. Global Sterile Formulation Development Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Sterile Formulation Development Market Share by Application: 2025 VS 2032 Figure 10. Preclinical Image Figure 11. Clinical Image Figure 12. Commercial Image Figure 13. Global Sterile Formulation Development Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 15. Global Sterile Formulation Development Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Sterile Formulation Development Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Sterile Formulation Development Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Sterile Formulation Development Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Sterile Formulation Development Revenue Market Share by Type (2021-2032) Figure 22. Global Sterile Formulation Development Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Sterile Formulation Development Revenue Market Share by Application (2021-2032) Figure 24. North America Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 25. North America Sterile Formulation Development Market Share by Type (2021-2032) Figure 26. North America Sterile Formulation Development Market Share by Application (2021-2032) Figure 27. North America Sterile Formulation Development Market Share by Country (2021-2032) Figure 28. United States Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 29. Canada Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 31. Europe Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 32. Europe Sterile Formulation Development Market Share by Type (2021-2032) Figure 33. Europe Sterile Formulation Development Market Share by Application (2021-2032) Figure 34. Europe Sterile Formulation Development Market Share by Country (2021-2032) Figure 35. Germany Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 36. France Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 38. Italy Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 39. Russia Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 41. China Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 42. China Sterile Formulation Development Market Share by Type (2021-2032) Figure 43. China Sterile Formulation Development Market Share by Application (2021-2032) Figure 44. Asia Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 45. Asia Sterile Formulation Development Market Share by Type (2021-2032) Figure 46. Asia Sterile Formulation Development Market Share by Application (2021-2032) Figure 47. Asia Sterile Formulation Development Market Share by Country (2021-2032) Figure 48. Japan Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 52. India Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 53. Australia Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Sterile Formulation Development Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Sterile Formulation Development Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Sterile Formulation Development Market Share by Country (2021-2032) Figure 58. Brazil Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 63. UAE Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 65. Chile Sterile Formulation Development Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid Dosage Form
  • Lyophilized Dosage Form
  • Frozen Dosage Form
  • Others
Applications
  • Preclinical
  • Clinical
  • Commercial
Companies covered
  • Catalent
  • Lonza Group AG
  • Recipharm AB
  • Samsung Biologics
  • Aenova Group
  • Thermo Fisher Scientific
  • Pfizer CentreOne
  • Piramal Pharma Solutions
  • Ardena
  • Curida
  • Curia Global
  • Carbogen Amcis
  • Oakwood Labs
  • Cambrex
  • Almac Group
  • Asymchem Group
  • AGC Biologics
  • WuXi AppTec
  • Althea
  • Baxter

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Sterile Formulation Development Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Liquid Dosage Form
  5. 1.2.3 Lyophilized Dosage Form
  6. 1.2.4 Frozen Dosage Form
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Sterile Formulation Development Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Preclinical
  11. 1.3.3 Clinical
  12. 1.3.4 Commercial
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Sterile Formulation Development Growth Trends by Region
  15. 1.5.1 Global Sterile Formulation Development Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Sterile Formulation Development Market Size by Region (2021-2026)
  17. 1.5.3 Sterile Formulation Development Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Sterile Formulation Development Market Dynamics
  1. 2.1 Sterile Formulation Development Industry Trends
  2. 2.2 Sterile Formulation Development Industry Drivers
  3. 2.3 Sterile Formulation Development Industry Opportunities and Challenges
  4. 2.4 Sterile Formulation Development Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Sterile Formulation Development Revenue by Company (2021-2026)
  2. 3.2 Global Sterile Formulation Development Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Sterile Formulation Development Key Company Head office and Area Served
  4. 3.4 Global Sterile Formulation Development Company, Product Type & Application
  5. 3.5 Global Sterile Formulation Development Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Sterile Formulation Development Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Sterile Formulation Development Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Sterile Formulation Development Tier 1, Tier 2, and Tier 3
4 Sterile Formulation Development Market by Type
  1. 4.1 Global Sterile Formulation Development Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Sterile Formulation Development Market Size by Type (2021-2032)
  3. 4.3 Global Sterile Formulation Development Market Size Share by Type (2021-2032)
5 Sterile Formulation Development Market by Application
  1. 5.1 Global Sterile Formulation Development Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Sterile Formulation Development Market Size by Application (2021-2032)
  3. 5.3 Global Sterile Formulation Development Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Catalent
  2. 6.1.1 Catalent Company Information
  3. 6.1.2 Catalent Business Overview
  4. 6.1.3 Catalent Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Catalent Sterile Formulation Development Product Portfolio
  6. 6.1.5 Catalent Recent Developments
  7. 6.2 Lonza Group AG
  8. 6.2.1 Lonza Group AG Company Information
  9. 6.2.2 Lonza Group AG Business Overview
  10. 6.2.3 Lonza Group AG Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Lonza Group AG Sterile Formulation Development Product Portfolio
  12. 6.2.5 Lonza Group AG Recent Developments
  13. 6.3 Recipharm AB
  14. 6.3.1 Recipharm AB Company Information
  15. 6.3.2 Recipharm AB Business Overview
  16. 6.3.3 Recipharm AB Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Recipharm AB Sterile Formulation Development Product Portfolio
  18. 6.3.5 Recipharm AB Recent Developments
  19. 6.4 Samsung Biologics
  20. 6.4.1 Samsung Biologics Company Information
  21. 6.4.2 Samsung Biologics Business Overview
  22. 6.4.3 Samsung Biologics Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Samsung Biologics Sterile Formulation Development Product Portfolio
  24. 6.4.5 Samsung Biologics Recent Developments
  25. 6.5 Aenova Group
  26. 6.5.1 Aenova Group Company Information
  27. 6.5.2 Aenova Group Business Overview
  28. 6.5.3 Aenova Group Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Aenova Group Sterile Formulation Development Product Portfolio
  30. 6.5.5 Aenova Group Recent Developments
  31. 6.6 Thermo Fisher Scientific
  32. 6.6.1 Thermo Fisher Scientific Company Information
  33. 6.6.2 Thermo Fisher Scientific Business Overview
  34. 6.6.3 Thermo Fisher Scientific Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Thermo Fisher Scientific Sterile Formulation Development Product Portfolio
  36. 6.6.5 Thermo Fisher Scientific Recent Developments
  37. 6.7 Pfizer CentreOne
  38. 6.7.1 Pfizer CentreOne Company Information
  39. 6.7.2 Pfizer CentreOne Business Overview
  40. 6.7.3 Pfizer CentreOne Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Pfizer CentreOne Sterile Formulation Development Product Portfolio
  42. 6.7.5 Pfizer CentreOne Recent Developments
  43. 6.8 Piramal Pharma Solutions
  44. 6.8.1 Piramal Pharma Solutions Company Information
  45. 6.8.2 Piramal Pharma Solutions Business Overview
  46. 6.8.3 Piramal Pharma Solutions Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Piramal Pharma Solutions Sterile Formulation Development Product Portfolio
  48. 6.8.5 Piramal Pharma Solutions Recent Developments
  49. 6.9 Ardena
  50. 6.9.1 Ardena Company Information
  51. 6.9.2 Ardena Business Overview
  52. 6.9.3 Ardena Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Ardena Sterile Formulation Development Product Portfolio
  54. 6.9.5 Ardena Recent Developments
  55. 6.10 Curida
  56. 6.10.1 Curida Company Information
  57. 6.10.2 Curida Business Overview
  58. 6.10.3 Curida Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Curida Sterile Formulation Development Product Portfolio
  60. 6.10.5 Curida Recent Developments
  61. 6.11 Curia Global
  62. 6.11.1 Curia Global Company Information
  63. 6.11.2 Curia Global Business Overview
  64. 6.11.3 Curia Global Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Curia Global Sterile Formulation Development Product Portfolio
  66. 6.11.5 Curia Global Recent Developments
  67. 6.12 Carbogen Amcis
  68. 6.12.1 Carbogen Amcis Company Information
  69. 6.12.2 Carbogen Amcis Business Overview
  70. 6.12.3 Carbogen Amcis Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Carbogen Amcis Sterile Formulation Development Product Portfolio
  72. 6.12.5 Carbogen Amcis Recent Developments
  73. 6.13 Oakwood Labs
  74. 6.13.1 Oakwood Labs Company Information
  75. 6.13.2 Oakwood Labs Business Overview
  76. 6.13.3 Oakwood Labs Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Oakwood Labs Sterile Formulation Development Product Portfolio
  78. 6.13.5 Oakwood Labs Recent Developments
  79. 6.14 Cambrex
  80. 6.14.1 Cambrex Company Information
  81. 6.14.2 Cambrex Business Overview
  82. 6.14.3 Cambrex Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Cambrex Sterile Formulation Development Product Portfolio
  84. 6.14.5 Cambrex Recent Developments
  85. 6.15 Almac Group
  86. 6.15.1 Almac Group Company Information
  87. 6.15.2 Almac Group Business Overview
  88. 6.15.3 Almac Group Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Almac Group Sterile Formulation Development Product Portfolio
  90. 6.15.5 Almac Group Recent Developments
  91. 6.16 Asymchem Group
  92. 6.16.1 Asymchem Group Company Information
  93. 6.16.2 Asymchem Group Business Overview
  94. 6.16.3 Asymchem Group Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Asymchem Group Sterile Formulation Development Product Portfolio
  96. 6.16.5 Asymchem Group Recent Developments
  97. 6.17 AGC Biologics
  98. 6.17.1 AGC Biologics Company Information
  99. 6.17.2 AGC Biologics Business Overview
  100. 6.17.3 AGC Biologics Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 AGC Biologics Sterile Formulation Development Product Portfolio
  102. 6.17.5 AGC Biologics Recent Developments
  103. 6.18 WuXi AppTec
  104. 6.18.1 WuXi AppTec Company Information
  105. 6.18.2 WuXi AppTec Business Overview
  106. 6.18.3 WuXi AppTec Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 WuXi AppTec Sterile Formulation Development Product Portfolio
  108. 6.18.5 WuXi AppTec Recent Developments
  109. 6.19 Althea
  110. 6.19.1 Althea Company Information
  111. 6.19.2 Althea Business Overview
  112. 6.19.3 Althea Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Althea Sterile Formulation Development Product Portfolio
  114. 6.19.5 Althea Recent Developments
  115. 6.20 Baxter
  116. 6.20.1 Baxter Company Information
  117. 6.20.2 Baxter Business Overview
  118. 6.20.3 Baxter Sterile Formulation Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Baxter Sterile Formulation Development Product Portfolio
  120. 6.20.5 Baxter Recent Developments
7 North America
  1. 7.1 North America Sterile Formulation Development Market Size (2021-2032)
  2. 7.2 North America Sterile Formulation Development Market Size by Type
  3. 7.2.1 North America Sterile Formulation Development Market Size by Type (2021-2026)
  4. 7.2.2 North America Sterile Formulation Development Market Size by Type (2027-2032)
  5. 7.2.3 North America Sterile Formulation Development Market Share by Type (2021-2032)
  6. 7.3 North America Sterile Formulation Development Market Size by Application
  7. 7.3.1 North America Sterile Formulation Development Market Size by Application (2021-2026)
  8. 7.3.2 North America Sterile Formulation Development Market Size by Application (2027-2032)
  9. 7.3.3 North America Sterile Formulation Development Market Share by Application (2021-2032)
  10. 7.4 North America Sterile Formulation Development Market Size by Country
  11. 7.4.1 North America Sterile Formulation Development Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Sterile Formulation Development Market Size by Country (2021-2026)
  13. 7.4.3 North America Sterile Formulation Development Market Size by Country (2027-2032)
  14. 7.4.4 North America Sterile Formulation Development Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Sterile Formulation Development Market Size (2021-2032)
  2. 8.2 Europe Sterile Formulation Development Market Size by Type
  3. 8.2.1 Europe Sterile Formulation Development Market Size by Type (2021-2026)
  4. 8.2.2 Europe Sterile Formulation Development Market Size by Type (2027-2032)
  5. 8.2.3 Europe Sterile Formulation Development Market Share by Type (2021-2032)
  6. 8.3 Europe Sterile Formulation Development Market Size by Application
  7. 8.3.1 Europe Sterile Formulation Development Market Size by Application (2021-2026)
  8. 8.3.2 Europe Sterile Formulation Development Market Size by Application (2027-2032)
  9. 8.3.3 Europe Sterile Formulation Development Market Share by Application (2021-2032)
  10. 8.4 Europe Sterile Formulation Development Market Size by Country
  11. 8.4.1 Europe Sterile Formulation Development Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Sterile Formulation Development Market Size by Country (2021-2026)
  13. 8.4.3 Europe Sterile Formulation Development Market Size by Country (2027-2032)
  14. 8.4.4 Europe Sterile Formulation Development Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Sterile Formulation Development Market Size (2021-2032)
  2. 9.2 China Sterile Formulation Development Market Size by Type
  3. 9.2.1 China Sterile Formulation Development Market Size by Type (2021-2026)
  4. 9.2.2 China Sterile Formulation Development Market Size by Type (2027-2032)
  5. 9.2.3 China Sterile Formulation Development Market Share by Type (2021-2032)
  6. 9.3 China Sterile Formulation Development Market Size by Application
  7. 9.3.1 China Sterile Formulation Development Market Size by Application (2021-2026)
  8. 9.3.2 China Sterile Formulation Development Market Size by Application (2027-2032)
  9. 9.3.3 China Sterile Formulation Development Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Sterile Formulation Development Market Size (2021-2032)
  2. 10.2 Asia Sterile Formulation Development Market Size by Type
  3. 10.2.1 Asia Sterile Formulation Development Market Size by Type (2021-2026)
  4. 10.2.2 Asia Sterile Formulation Development Market Size by Type (2027-2032)
  5. 10.2.3 Asia Sterile Formulation Development Market Share by Type (2021-2032)
  6. 10.3 Asia Sterile Formulation Development Market Size by Application
  7. 10.3.1 Asia Sterile Formulation Development Market Size by Application (2021-2026)
  8. 10.3.2 Asia Sterile Formulation Development Market Size by Application (2027-2032)
  9. 10.3.3 Asia Sterile Formulation Development Market Share by Application (2021-2032)
  10. 10.4 Asia Sterile Formulation Development Market Size by Country
  11. 10.4.1 Asia Sterile Formulation Development Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Sterile Formulation Development Market Size by Country (2021-2026)
  13. 10.4.3 Asia Sterile Formulation Development Market Size by Country (2027-2032)
  14. 10.4.4 Asia Sterile Formulation Development Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Sterile Formulation Development Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Sterile Formulation Development Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Sterile Formulation Development Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Sterile Formulation Development Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Sterile Formulation Development Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Sterile Formulation Development Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Sterile Formulation Development Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Sterile Formulation Development Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Sterile Formulation Development Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Sterile Formulation Development Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Sterile Formulation Development Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Sterile Formulation Development Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Sterile Formulation Development Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Sterile Formulation Development Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst